AEs similar across COVID-19 vaccines in Europe: Data Byte

At least 20 European countries have temporarily suspended the use of AstraZeneca’s COVID-19 vaccine due to concerns around thromboembolic events, but the rates of the side effects show little difference from the other two COVID-19 vaccines being distributed in Europe, and may not be above background levels in the general population.

According to the European Center for Disease Prevention and Control (ECDC), as of March 15 there had been 48.1 million doses administered across EU states, with Comirnaty from Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) accounting for 37.5 million (78%) of the doses. The remainder were from AstraZeneca plc (LSE:AZN; NASDAQ:AZN) and Moderna Inc. (NASDAQ:MRNA)...